HemoCept device data collection during diagnostic right heart catheterization

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center observational pilot will collect continuous HemoCept device data from adult patients undergoing clinically indicated diagnostic right heart catheterization (RHC) at Boulder Heart. The device will be used during standard-of-care RHC or combined RHC+LHC procedures without altering clinical treatment. Collected device signals and time-synced clinical hemodynamic measurements will be compiled to characterize device performance and data quality. The study will enroll consenting adults aged 18 and older and excludes pregnant or breastfeeding participants.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
* Subjects can be any gender but must be age 18 or older.
* Subject is able and willing to provide informed consent and HIPAA authorization.
* Subject is able and willing to meet all study requirements.
* Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)

Exclusion Criteria:

* Subject is pregnant, breastfeeding, or intends to become pregnant during this study.

Where it's running

• Boulder Heart
  Boulder, Colorado, United States Recruiting

Study contacts

• Study coordinator: Katharine Adkins
• Email: kathari.adkins@bch.org
• Phone: 303-442-2395

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Pedal Pump Device for Lower Extremity Edema in Hospitalized Patients

  This study tests a foot-pump device to see if it is tolerable and can help reduce swelling in the legs of hospitalized patients with edema.

  Recruiting Hillcrest · Tulsa, Oklahoma · NCT07760363

• Nonintubated anesthesia for adults undergoing cardiac surgery with bypass

  This trial tests a nonintubated airway approach with the goal of seeing if avoiding endotracheal intubation during elective valve or bypass surgery can reduce lung problems and help patients recover faster.

  Recruiting The First Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT07744009

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.